Project Grant R35GM156045

Award Date 5/5/25
Completion Date 3/31/30
Dollars Obligated $550K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This $463,157 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), supports research to measure and model how antimicrobial resistance (AMR) evolution depends on the self-organization of bacterial populations. The principal investigators at the University of California, Berkeley will leverage microfluidics, synthetic biology, and advanced imaging techniques to track the...
The National Institute of General Medical Sciences (NIGMS) awarded the University of California, Santa Cruz (UCSC) a $133,246 project grant under the Biomedical Research and Research Training Program (CFDA 93.859) to develop flexible Bayesian statistical methods for comprehensive analysis of microbial community dynamics using high-throughput sequencing data. The key objectives of this 3-year project are to: 1) create general methods for inferring microbial community dynamics in relation to...
The National Institute of General Medical Sciences (NIGMS) awarded a $382,136 Project Grant (CFDA 93.859 Biomedical Research and Research Training) to the University of Maryland, College Park to develop engineering principles for designing programmable bioengineered multicellular structures (probioms) in prokaryotic cells. The goal is to create a new class of probiotic-based therapeutic materials that can be tailored for various biomedical applications, such as anticavity pastes, vaginal creams,...
This $802,500 Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), funds research to understand the molecular mechanisms by which cell wall-anchored proteins on the surface of Staphylococcus epidermidis and S. aureus promote biofilm formation and virulence. The key objectives are to study the self-assembly and nucleation of functional amyloid fibrils, the interactions between secreted and...
This $368,774 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support research at the University of Oregon to investigate how the host nutrient environment regulates the physiology of Gram-positive anaerobic cocci (GPAC) bacteria. The goal is to better understand the mechanisms that enable these bacteria to adopt recalcitrant states like slow growth and biofilm formation, which...
This $854,736 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the development of robust statistical methods for analyzing longitudinal microbiome data. The project aims to create a comprehensive suite of tools to address key challenges in longitudinal microbiome studies, including addressing batch effects, identifying taxa associated with exposures/outcomes over time, detecting...
This $462,500 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) aims to decipher the genetic regulation of bacterial heterogeneity in response to antibiotic stress using single-cell transcriptomics. The award will fund a 5-year research project led by St. Jude Children's Research Hospital to comprehensively characterize bacterial heterogeneity under antibiotic treatment and identify the...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $853,193 over the period of May 20, 2024 to April 30, 2028 to the University of California, Merced (UC Merced) to conduct research on Candida albicans, a leading cause of life-threatening fungal infections in hospitals. The key objectives of the research project are to: 1) Identify opaque-specific virulence genes in C....
This federal Project Grant award, valued at $866,825 and provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research focused on understanding how the fungus Candida albicans colonizes the gastrointestinal (GI) tract and interacts with the gut microbiome. The primary objectives of this 5-year project are to: 1) examine how C. albicans morphology and gene regulation influence its fitness...
The National Institute of General Medical Sciences (NIGMS), through its Biomedical Research and Research Training Program (CFDA 93.859), awarded a $433,459 Project Grant to the University of Kansas Center for Research Inc. effective January 10, 2025. This award supports research to expand the understanding of quorum sensing - a type of bacterial cell-cell communication - and its role in the behavior and evolution of mixed microbial communities. The proposed studies focus on three key areas: 1)...

This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $550,108 to the University of California, Merced for a research project focused on understanding the genetic regulation of microbial community formation, particularly related to biofilms. The project aims to investigate the molecular and mechanistic bases of biofilm microbial communities, including how transcriptional networks underlie gene expression during biofilm development. The research will explore single-species biofilms formed by the fungal pathogen Candida albicans, as well as dual-species biofilms involving C. albicans and other microbiota members. This work is expected to provide new insights into detecting, treating, and preventing biofilm infections, with potential to lead to innovative prevention, diagnostic, and therapeutic strategies for combating such infections. The project period runs from May 5, 2025 to March 31, 2030.

Generated 5/13/25, 4:48 AM